Interactive or static reports to guide clinical interpretation of cancer genomics
暂无分享,去创建一个
Eliezer M. Van Allen | Ethan Cerami | Hajime Uno | Charlotte Lee | Jordan Bryan | Angel M. Cronin | Stacy W. Gray | Lynette Sholl | Jeffrey Gagan | Nelly Oliver | Carol Lowenstein | Ruth Lederman | Anna Revette | Aaron Suarez | Jordan G Bryan | H. Uno | E. Cerami | Anna Revette | S. Gray | L. Sholl | E. Allen | A. Cronin | J. Gagan | Nelly Oliver | R. Lederman | C. Lowenstein | A. Suarez | Charlotte Lee | Jordan G. Bryan
[1] Peter Tarczy-Hornoch,et al. Refining the structure and content of clinical genomic reports , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[2] R. Croyle,et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[3] Jonathan M Marron,et al. Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling , 2016, Annals of Surgical Oncology.
[4] Lee T. Sam,et al. Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study , 2011, Science Translational Medicine.
[5] D. Bates,et al. Appropriateness: A Key to Enabling the Use of Genomics in Clinical Practice? , 2016, American Journal of Medicine.
[6] Moriah H Nissan,et al. OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.
[7] N. Holtzman,et al. Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing? , 2003, Genetics in Medicine.
[8] Carrie Cibulskis,et al. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study , 2017, Genetics in Medicine.
[9] Razelle Kurzrock,et al. Breast Cancer Experience of the Molecular Tumor Board at the University of California, San Diego Moores Cancer Center. , 2015, Journal of oncology practice.
[10] Marie-Cécile Le Deley,et al. High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial. , 2017, Cancer discovery.
[11] Nicolas Servant,et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. , 2015, The Lancet. Oncology.
[12] Christopher G. Chute,et al. CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record , 2015, J. Am. Medical Informatics Assoc..
[13] S. Kamel‐Reid,et al. Postal survey of physicians and laboratories: Practices and perceptions of molecular oncology testing , 2009, BMC health services research.
[14] Tao Wang,et al. Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors. , 2016, JAMA oncology.
[15] L. Macconaill,et al. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. , 2017, Archives of pathology & laboratory medicine.
[16] E. Smets,et al. Non-genetic health professionals’ attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer , 2015, Familial Cancer.
[17] Andy Anderson,et al. Physicians' preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system. , 2013, Genetic testing and molecular biomarkers.
[18] C. Ponting,et al. Sequencing depth and coverage: key considerations in genomic analyses , 2014, Nature Reviews Genetics.
[19] G. Abel,et al. Increasing response rates from physicians in oncology research: a structured literature review and data from a recent physician survey , 2012, British Journal of Cancer.
[20] Marc S. Williams,et al. Enhancing genomic laboratory reports: A qualitative analysis of provider review , 2016, American journal of medical genetics. Part A.
[21] E. V. Van Allen,et al. Next-generation sequencing to guide cancer therapy , 2015, Genome Medicine.
[22] Robert C. Green,et al. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium , 2013, Genetics in Medicine.
[23] K. Nichols,et al. Integrating next‐generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics , 2017, Cancer.
[24] Gary D Bader,et al. Computational approaches to identify functional genetic variants in cancer genomes , 2013, Nature Methods.
[25] Joshua S. Paul,et al. Genotype and SNP calling from next-generation sequencing data , 2011, Nature Reviews Genetics.
[26] Donavan T. Cheng,et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.
[27] Jane C Weeks,et al. Physicians' attitudes about multiplex tumor genomic testing. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Matthew S. Lebo,et al. A systematic approach to the reporting of medically relevant findings from whole genome sequencing , 2014, BMC Medical Genetics.
[29] Gavin R. Oliver,et al. Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery , 2017, Oncotarget.
[30] Matthew S. Lebo,et al. A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record , 2013, Genetics in Medicine.
[31] William Pao,et al. DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): A Catalog of Clinically Relevant Cancer Mutations to Enable Genome-Directed Anticancer Therapy , 2013, Clinical Cancer Research.
[32] Nikhil Wagle,et al. The fuzzy world of precision medicine: deliberations of a precision medicine tumor board , 2016, Personalized medicine.
[33] Ira M. Lubin,et al. Effective communication of molecular genetic test results to primary care providers , 2012, Genetics in Medicine.
[34] R. Green,et al. Genomic sequencing in clinical practice: applications, challenges, and opportunities , 2016, Dialogues in clinical neuroscience.
[35] Denise L. Perry,et al. Are physicians prepared for whole genome sequencing? a qualitative analysis , 2016, Clinical genetics.
[36] Steven J. M. Jones,et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer , 2017, Nature Genetics.
[37] L. Garraway,et al. Oncologists' and Cancer Patients' Views on Whole-Exome Sequencing and Incidental Findings: Results from The CanSeq Study , 2016, Genetics in Medicine.
[38] Levi A Garraway,et al. Genomics-driven oncology: framework for an emerging paradigm. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] Marian Harris,et al. Institutional implementation of clinical tumor profiling on an unselected cancer population. , 2016, JCI insight.